2024 Q2 Form 10-Q Financial Statement

#000152716624000051 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.070B $688.4M
YoY Change 131.49% -19.86%
Cost Of Revenue $326.4M $82.80M
YoY Change 703.94% -63.86%
Gross Profit $743.3M $605.6M
YoY Change 76.35% -3.86%
Gross Profit Margin 69.49% 87.97%
Selling, General & Admin $519.4M $477.9M
YoY Change 12.04% 11.35%
% of Gross Profit 69.88% 78.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $45.50M $45.30M
YoY Change 3.17% 2.95%
% of Gross Profit 6.12% 7.48%
Operating Expenses $519.4M $477.9M
YoY Change 4.63% 3.44%
Operating Profit $223.9M $127.7M
YoY Change -398.93% -23.94%
Interest Expense -$5.100M -$7.000M
YoY Change -204.08% -123.57%
% of Operating Profit -2.28% -5.48%
Other Income/Expense, Net $300.0K $0.00
YoY Change -100.0%
Pretax Income $218.8M $120.7M
YoY Change -412.57% -24.37%
Income Tax $69.50M $21.90M
% Of Pretax Income 31.76% 18.14%
Net Earnings $148.2M $65.60M
YoY Change -250.61% -34.86%
Net Earnings / Revenue 13.85% 9.53%
Basic Earnings Per Share $0.41 $0.18
Diluted Earnings Per Share $0.40 $0.18
COMMON SHARES
Basic Shares Outstanding 359.9M shares 362.1M shares
Diluted Shares Outstanding 366.9M shares 369.3M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.962B $1.703B
YoY Change 39.5% 37.42%
Cash & Equivalents $1.962B $1.703B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $228.4M $204.1M
Other Receivables $715.4M $624.1M
Total Short-Term Assets $2.906B $2.531B
YoY Change 36.49% 37.63%
LONG-TERM ASSETS
Property, Plant & Equipment $521.5M $512.1M
YoY Change 4.63% 261.14%
Goodwill $103.9M $103.9M
YoY Change -0.1% -0.1%
Intangibles
YoY Change
Long-Term Investments $18.11B $17.02B
YoY Change 59.29% 483.77%
Other Assets $50.50M $53.60M
YoY Change 157.65% 73.46%
Total Long-Term Assets $19.38B $18.32B
YoY Change 0.66% -5.74%
TOTAL ASSETS
Total Short-Term Assets $2.906B $2.531B
Total Long-Term Assets $19.38B $18.32B
Total Assets $22.28B $20.85B
YoY Change 4.22% -1.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $371.1M $375.2M
YoY Change 13.31% 23.1%
Accrued Expenses $4.878B $4.721B
YoY Change 12.08% 6.56%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $46.30M $101.4M
YoY Change -26.97% 199.12%
Total Short-Term Liabilities $5.462B $5.300B
YoY Change 8.43% 4.27%
LONG-TERM LIABILITIES
Long-Term Debt $10.04B $8.794B
YoY Change 15.22% 286.45%
Other Long-Term Liabilities $1.030B $989.6M
YoY Change 51.86% 49.37%
Total Long-Term Liabilities $11.07B $9.784B
YoY Change 17.87% 329.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.462B $5.300B
Total Long-Term Liabilities $11.07B $9.784B
Total Liabilities $16.55B $15.11B
YoY Change 7.38% 4.47%
SHAREHOLDERS EQUITY
Retained Earnings $1.708B $1.868B
YoY Change -42.94% -43.06%
Common Stock $3.600M $3.600M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.729B $5.740B
YoY Change
Total Liabilities & Shareholders Equity $22.28B $20.85B
YoY Change 4.22% -1.99%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $148.2M $65.60M
YoY Change -250.61% -34.86%
Depreciation, Depletion And Amortization $45.50M $45.30M
YoY Change 3.17% 2.95%
Cash From Operating Activities -$1.270B $71.10M
YoY Change 72.4% -163.2%
INVESTING ACTIVITIES
Capital Expenditures $17.70M $14.20M
YoY Change -9.69% 10.08%
Acquisitions
YoY Change
Other Investing Activities -$5.000M
YoY Change -108.59%
Cash From Investing Activities -$22.70M -$14.20M
YoY Change -158.81% -84.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 933.9M -$216.7M
YoY Change 71.52% 58.75%
NET CHANGE
Cash From Operating Activities -1.270B $71.10M
Cash From Investing Activities -22.70M -$14.20M
Cash From Financing Activities 933.9M -$216.7M
Net Change In Cash -358.5M -$164.2M
YoY Change 133.7% -50.93%
FREE CASH FLOW
Cash From Operating Activities -$1.270B $71.10M
Capital Expenditures $17.70M $14.20M
Free Cash Flow -$1.287B $56.90M
YoY Change 70.27% -145.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://www.carlyle.com/20240331#NetInvestmentGainsLossesOfConsolidatedFunds
CY2023Q1 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://www.carlyle.com/20240331#NetInvestmentGainsLossesOfConsolidatedFunds
CY2020Q1 cg Termination Of Tax Receivable Agreement Term Of Annual Installments
TerminationOfTaxReceivableAgreementTermOfAnnualInstallments
P5Y
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
359260138 shares
CY2024Q1 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
-83900000 usd
CY2023Q1 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
172500000 usd
CY2024Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
57600000 usd
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
44000000.0 usd
CY2024Q1 cg Interest And Other Income Of Consolidated Funds
InterestAndOtherIncomeOfConsolidatedFunds
164900000 usd
CY2023Q1 cg Interest And Other Income Of Consolidated Funds
InterestAndOtherIncomeOfConsolidatedFunds
121900000 usd
CY2024Q1 us-gaap Revenues
Revenues
688400000 usd
CY2023Q1 us-gaap Revenues
Revenues
859000000.0 usd
CY2024Q1 us-gaap Salaries And Wages
SalariesAndWages
221900000 usd
CY2023Q1 us-gaap Salaries And Wages
SalariesAndWages
260200000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
108300000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
54400000 usd
CY2024Q1 cg Performance Allocations And Incentive Fee Expense
PerformanceAllocationsAndIncentiveFeeExpense
-72800000 usd
CY2023Q1 cg Performance Allocations And Incentive Fee Expense
PerformanceAllocationsAndIncentiveFeeExpense
105700000 usd
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
257400000 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
420300000 usd
CY2024Q1 cg General Administrative And Other Expense
GeneralAdministrativeAndOtherExpense
147700000 usd
CY2023Q1 cg General Administrative And Other Expense
GeneralAdministrativeAndOtherExpense
159200000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
30800000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
29700000 usd
CY2024Q1 cg Interest And Other Expenses Of Consolidated Funds
InterestAndOtherExpensesOfConsolidatedFunds
124600000 usd
CY2023Q1 cg Interest And Other Expenses Of Consolidated Funds
InterestAndOtherExpensesOfConsolidatedFunds
93700000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-200000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-100000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
560700000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
703000000.0 usd
CY2024Q1 cg Net Investment Gains Losses Of Consolidated Funds
NetInvestmentGainsLossesOfConsolidatedFunds
-7000000.0 usd
CY2023Q1 cg Net Investment Gains Losses Of Consolidated Funds
NetInvestmentGainsLossesOfConsolidatedFunds
3600000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
120700000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
159600000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21900000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34300000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
98800000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
125300000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
33200000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
24600000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
65600000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
100700000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
360908247 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
362944260 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
369343601 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
365357833 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
98800000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
125300000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-20700000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
19800000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-400000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-300000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
-100000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
-100000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-20400000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
20000000.0 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
78400000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
145300000 usd
CY2024Q1 cg Comprehensive Income Loss Net Of Tax Attributable To Noncontrolling Interest In Consolidated Entities
ComprehensiveIncomeLossNetOfTaxAttributableToNoncontrollingInterestInConsolidatedEntities
30500000 usd
CY2023Q1 cg Comprehensive Income Loss Net Of Tax Attributable To Noncontrolling Interest In Consolidated Entities
ComprehensiveIncomeLossNetOfTaxAttributableToNoncontrollingInterestInConsolidatedEntities
27600000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
47900000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
117700000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5784500000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
131200000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-19400000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
108700000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
0 usd
CY2024Q1 cg Noncontrolling Interest Increase For Contributions From Noncontrolling Interest Holders
NoncontrollingInterestIncreaseForContributionsFromNoncontrollingInterestHolders
64700000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
145700000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
98800000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-20700000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-300000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5740000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6821300000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
100300000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
54800000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
0 usd
CY2023Q1 cg Noncontrolling Interest Increase For Contributions From Noncontrolling Interest Holders
NoncontrollingInterestIncreaseForContributionsFromNoncontrollingInterestHolders
18700000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
128300000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
125300000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
19800000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-200000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6811500000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
98800000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
125300000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
45300000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44000000.0 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
108300000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
54400000 usd
CY2024Q1 cg Non Cash Performance Allocations And Incentive Fees Gain Loss
NonCashPerformanceAllocationsAndIncentiveFeesGainLoss
-190900000 usd
CY2023Q1 cg Non Cash Performance Allocations And Incentive Fees Gain Loss
NonCashPerformanceAllocationsAndIncentiveFeesGainLoss
36700000 usd
CY2024Q1 cg Non Cash Principal Investment Income
NonCashPrincipalInvestmentIncome
70000000.0 usd
CY2023Q1 cg Non Cash Principal Investment Income
NonCashPrincipalInvestmentIncome
7700000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2900000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-10800000 usd
CY2024Q1 cg Realized Unrealized Gain Loss On Investments Of Consolidated Funds
RealizedUnrealizedGainLossOnInvestmentsOfConsolidatedFunds
82700000 usd
CY2023Q1 cg Realized Unrealized Gain Loss On Investments Of Consolidated Funds
RealizedUnrealizedGainLossOnInvestmentsOfConsolidatedFunds
145000000.0 usd
CY2024Q1 cg Realized Unrealized Gain Loss From Loans Payable Of Consolidated Funds
RealizedUnrealizedGainLossFromLoansPayableOfConsolidatedFunds
-89700000 usd
CY2023Q1 cg Realized Unrealized Gain Loss From Loans Payable Of Consolidated Funds
RealizedUnrealizedGainLossFromLoansPayableOfConsolidatedFunds
-141400000 usd
CY2024Q1 cg Purchases Of Investments By Consolidated Funds
PurchasesOfInvestmentsByConsolidatedFunds
1477300000 usd
CY2023Q1 cg Purchases Of Investments By Consolidated Funds
PurchasesOfInvestmentsByConsolidatedFunds
386600000 usd
CY2024Q1 cg Proceeds From Sale And Settlements Of Investments By Consolidated Funds
ProceedsFromSaleAndSettlementsOfInvestmentsByConsolidatedFunds
1276300000 usd
CY2023Q1 cg Proceeds From Sale And Settlements Of Investments By Consolidated Funds
ProceedsFromSaleAndSettlementsOfInvestmentsByConsolidatedFunds
332500000 usd
CY2024Q1 cg Non Cash Interest Income Net Of Consolidated Funds
NonCashInterestIncomeNetOfConsolidatedFunds
6700000 usd
CY2023Q1 cg Non Cash Interest Income Net Of Consolidated Funds
NonCashInterestIncomeNetOfConsolidatedFunds
3700000 usd
CY2024Q1 cg Increase Decrease In Cash And Cash Equivalents Held At Consolidated Funds
IncreaseDecreaseInCashAndCashEquivalentsHeldAtConsolidatedFunds
80000000.0 usd
CY2023Q1 cg Increase Decrease In Cash And Cash Equivalents Held At Consolidated Funds
IncreaseDecreaseInCashAndCashEquivalentsHeldAtConsolidatedFunds
20800000 usd
CY2024Q1 cg Increase Decrease Other Receivables Held At Consolidated Funds
IncreaseDecreaseOtherReceivablesHeldAtConsolidatedFunds
65000000.0 usd
CY2023Q1 cg Increase Decrease Other Receivables Held At Consolidated Funds
IncreaseDecreaseOtherReceivablesHeldAtConsolidatedFunds
-7100000 usd
CY2024Q1 cg Increase Decrease Other Liabilities Held At Consolidated Funds
IncreaseDecreaseOtherLiabilitiesHeldAtConsolidatedFunds
227900000 usd
CY2023Q1 cg Increase Decrease Other Liabilities Held At Consolidated Funds
IncreaseDecreaseOtherLiabilitiesHeldAtConsolidatedFunds
-32800000 usd
CY2024Q1 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
145100000 usd
CY2023Q1 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
18500000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
102100000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
78600000 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
1500000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
68600000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
47100000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
15100000 usd
CY2024Q1 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-6700000 usd
CY2023Q1 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-16900000 usd
CY2024Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
19700000 usd
CY2023Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
33900000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
41500000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-63900000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-365600000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-371900000 usd
CY2024Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-2200000 usd
CY2023Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-200000 usd
CY2024Q1 cg Increase Decrease In Right Of Use Asset And Lease Liability
IncreaseDecreaseInRightOfUseAssetAndLeaseLiability
-2200000 usd
CY2023Q1 cg Increase Decrease In Right Of Use Asset And Lease Liability
IncreaseDecreaseInRightOfUseAssetAndLeaseLiability
-2800000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
251600000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
284700000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
71100000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-112500000 usd
CY2024Q1 cg Payments To Acquire Corporate Treasury Investments Net
PaymentsToAcquireCorporateTreasuryInvestmentsNet
0 usd
CY2023Q1 cg Payments To Acquire Corporate Treasury Investments Net
PaymentsToAcquireCorporateTreasuryInvestmentsNet
101100000 usd
CY2024Q1 cg Proceeds From Corporate Treasury Investments Net
ProceedsFromCorporateTreasuryInvestmentsNet
0 usd
CY2023Q1 cg Proceeds From Corporate Treasury Investments Net
ProceedsFromCorporateTreasuryInvestmentsNet
20100000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14200000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12900000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14200000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-93900000 usd
CY2024Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
13900000 usd
CY2023Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
1100000 usd
CY2024Q1 cg Proceeds From Repayments Of Loans Payable Of Consolidated Funds
ProceedsFromRepaymentsOfLoansPayableOfConsolidatedFunds
45300000 usd
CY2023Q1 cg Proceeds From Repayments Of Loans Payable Of Consolidated Funds
ProceedsFromRepaymentsOfLoansPayableOfConsolidatedFunds
68700000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
126700000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
118400000 usd
CY2024Q1 cg Payment Of Deferred Consideration For Partnership Units
PaymentOfDeferredConsiderationForPartnershipUnits
68800000 usd
CY2023Q1 cg Payment Of Deferred Consideration For Partnership Units
PaymentOfDeferredConsiderationForPartnershipUnits
68800000 usd
CY2024Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
64700000 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
18700000 usd
CY2024Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
19000000.0 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
9900000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
150000000.0 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
100300000 usd
CY2024Q1 cg Change In Due To From Affiliates Financing Activities
ChangeInDueToFromAffiliatesFinancingActivities
-51700000 usd
CY2023Q1 cg Change In Due To From Affiliates Financing Activities
ChangeInDueToFromAffiliatesFinancingActivities
-74600000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-216700000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-136500000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4400000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8300000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-164200000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-334600000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1442100000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1361500000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1277900000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1026900000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1276500000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1010100000 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
1400000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
16800000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1277900000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1026900000 usd
CY2024Q1 cg Cash And Cash Equivalents At Carrying Value Held At Consolidated Funds
CashAndCashEquivalentsAtCarryingValueHeldAtConsolidatedFunds
426000000.0 usd
CY2023Q1 cg Cash And Cash Equivalents At Carrying Value Held At Consolidated Funds
CashAndCashEquivalentsAtCarryingValueHeldAtConsolidatedFunds
228800000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q1 cg Consolidated Collateralized Loan Obligations Investments
ConsolidatedCollateralizedLoanObligationsInvestments
184400000 usd
CY2024Q1 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
319900000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="font-family: Times New Roman; font-size: 10pt; font-style: normal; font-weight: bold; left: 74.25pt; position: var(--position); text-decoration: none; white-space: pre;">Use of Estimates<span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 295.5pt; width: 612pt;"><span style="font-family: Times New Roman; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.25pt; position: var(--position); text-decoration: none; white-space: pre;">The preparation of financial statements in conformity with U.S. GAAP requires management to make assumptions and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.5pt; width: 612pt;"><span style="font-family: Times New Roman; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.5pt; position: var(--position); text-decoration: none; white-space: pre;">estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.5pt; width: 612pt;"><span style="font-family: Times New Roman; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.5pt; position: var(--position); text-decoration: none; white-space: pre;">the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 331.5pt; width: 612pt;"><span style="font-family: Times New Roman; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.5pt; position: var(--position); text-decoration: none; white-space: pre;">period. Management’s estimates are based on historical experiences and other factors, including expectations of future events <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 343.5pt; width: 612pt;"><span style="font-family: Times New Roman; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.5pt; position: var(--position); text-decoration: none; white-space: pre;">that management believes to be reasonable under the circumstances. It also requires management to exercise judgment in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 355.5pt; width: 612pt;"><span style="font-family: Times New Roman; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.5pt; position: var(--position); text-decoration: none; white-space: pre;">process of applying the Company’s accounting policies. Assumptions and estimates regarding the valuation of investments and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 367.5pt; width: 612pt;"><span style="font-family: Times New Roman; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.5pt; position: var(--position); text-decoration: none; white-space: pre;">their resulting impact on performance allocations and incentive fees involve a higher degree of judgment and complexity and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 379.5pt; width: 612pt;"><span style="font-family: Times New Roman; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.5pt; position: var(--position); text-decoration: none; white-space: pre;">these assumptions and estimates may be significant to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: Times New Roman; font-size: 10pt; font-style: normal; font-weight: normal; left: 267.57pt; position: var(--position); text-decoration: none; white-space: pre;">the condensed c<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: Times New Roman; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.38pt; position: var(--position); text-decoration: none; white-space: pre;">onsolidated financial statements and the resulting impact <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 391.5pt; width: 612pt;"><span style="font-family: Times New Roman; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.5pt; position: var(--position); text-decoration: none; white-space: pre;">on performance allocations and incentive fees. Actual results could differ from these estimates and such differences could be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 403.5pt; width: 612pt;"><span style="font-family: Times New Roman; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.5pt; position: var(--position); text-decoration: none; white-space: pre;">material.<span style="display: inline-block; height: 6.93pt;"></span></span></div>
CY2024Q1 cg Period For Management Fees Received By Partners From Initial Closing Date
PeriodForManagementFeesReceivedByPartnersFromInitialClosingDate
P10Y
CY2024Q1 cg Subsequent Period Management Fees Recognized After Called
SubsequentPeriodManagementFeesRecognizedAfterCalled
P6M
CY2024Q1 cg Annual Management Fee Rate For Interval Funds
AnnualManagementFeeRateForIntervalFunds
0.010
CY2024Q1 cg Percentage Of Monthly Management Fee
PercentageOfMonthlyManagementFee
0.0125
CY2024Q1 cg Transaction And Portfolio Advisory Fee Rebate Offset Percentage
TransactionAndPortfolioAdvisoryFeeRebateOffsetPercentage
1
CY2024Q1 cg Transaction And Portfolio Advisory Fees Included In Fund Management Fees
TransactionAndPortfolioAdvisoryFeesIncludedInFundManagementFees
23800000 usd
CY2023Q1 cg Transaction And Portfolio Advisory Fees Included In Fund Management Fees
TransactionAndPortfolioAdvisoryFeesIncludedInFundManagementFees
13400000 usd
CY2024Q1 cg Performance Fees Allocation Percentage To Partnership
PerformanceFeesAllocationPercentageToPartnership
0.20
CY2024Q1 cg Accrued Giveback Obligations
AccruedGivebackObligations
44000000 usd
CY2023Q4 cg Accrued Giveback Obligations
AccruedGivebackObligations
44000000 usd
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
142600000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
109800000 usd
CY2024Q1 cg Accrued Performance Fees Due To Employees And Advisors Included In Accrued Compensation
AccruedPerformanceFeesDueToEmployeesAndAdvisorsIncludedInAccruedCompensation
3900000000 usd
CY2023Q4 cg Accrued Performance Fees Due To Employees And Advisors Included In Accrued Compensation
AccruedPerformanceFeesDueToEmployeesAndAdvisorsIncludedInAccruedCompensation
4300000000 usd
CY2024Q1 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
294500000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
500000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-11800000 usd
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
8167500000 usd
CY2024Q1 us-gaap Loans Payable Fair Value Disclosure
LoansPayableFairValueDisclosure
6352300000 usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
700000 usd
CY2024Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
6353000000 usd
CY2023Q4 us-gaap Alternative Investment
AlternativeInvestment
7962900000 usd
CY2023Q4 us-gaap Loans Payable Fair Value Disclosure
LoansPayableFairValueDisclosure
6298600000 usd
CY2023Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
6298600000 usd
CY2024Q1 cg Accrued Performance Based Capital Allocation
AccruedPerformanceBasedCapitalAllocation
5567600000 usd
CY2023Q4 cg Accrued Performance Based Capital Allocation
AccruedPerformanceBasedCapitalAllocation
6169900000 usd
CY2024Q1 cg Equity Method Investment Excluding Performance Allocations
EquityMethodInvestmentExcludingPerformanceAllocations
3145400000 usd
CY2023Q4 cg Equity Method Investment Excluding Performance Allocations
EquityMethodInvestmentExcludingPerformanceAllocations
3024100000 usd
CY2024Q1 cg Principal Investments In Collateralized Loan Obligations
PrincipalInvestmentsInCollateralizedLoanObligations
520800000 usd
CY2023Q4 cg Principal Investments In Collateralized Loan Obligations
PrincipalInvestmentsInCollateralizedLoanObligations
532600000 usd
CY2024Q1 cg Principal Investments In Other Investments
PrincipalInvestmentsInOtherInvestments
239400000 usd
CY2023Q4 cg Principal Investments In Other Investments
PrincipalInvestmentsInOtherInvestments
228700000 usd
CY2024Q1 us-gaap Investments
Investments
9473200000 usd
CY2023Q4 us-gaap Investments
Investments
9955300000 usd
CY2024Q1 cg Accrued Performance Fees
AccruedPerformanceFees
5567600000 usd
CY2023Q4 cg Accrued Performance Fees
AccruedPerformanceFees
6169900000 usd
CY2023Q4 cg Number Of Partnerships Corporate Private Equity Funds Related To Accrued Performance Fees
NumberOfPartnershipsCorporatePrivateEquityFundsRelatedToAccruedPerformanceFees
0 financingvehicle
CY2024Q1 cg Number Of Partnerships Corporate Private Equity Funds Related To Accrued Performance Fees
NumberOfPartnershipsCorporatePrivateEquityFundsRelatedToAccruedPerformanceFees
0 financingvehicle
CY2024Q1 cg Accrued Giveback Obligations
AccruedGivebackObligations
44000000.0 usd
CY2023Q4 cg Accrued Giveback Obligations
AccruedGivebackObligations
44000000.0 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
3145400000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
3024100000 usd
CY2024Q1 cg Percentage Of Carried Interest Income Allocated To Partnership For Future Carry Funds
PercentageOfCarriedInterestIncomeAllocatedToPartnershipForFutureCarryFunds
0.475
CY2024Q1 us-gaap Investment Income Net
InvestmentIncomeNet
-83900000 usd
CY2023Q1 us-gaap Investment Income Net
InvestmentIncomeNet
172500000 usd
CY2024Q1 cg Performance Allocation Investment Income Loss
PerformanceAllocationInvestmentIncomeLoss
-157000000.0 usd
CY2023Q1 cg Performance Allocation Investment Income Loss
PerformanceAllocationInvestmentIncomeLoss
160800000 usd
CY2024Q1 cg Minimum Percent Of Aggregate Assets For Individual Investments With Fair Value
MinimumPercentOfAggregateAssetsForIndividualInvestmentsWithFairValue
0.05
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
142600000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
109800000 usd
CY2024Q1 us-gaap Other Income
OtherIncome
22300000 usd
CY2023Q1 us-gaap Other Income
OtherIncome
12100000 usd
CY2024Q1 cg Interest And Other Income Of Consolidated Funds
InterestAndOtherIncomeOfConsolidatedFunds
164900000 usd
CY2023Q1 cg Interest And Other Income Of Consolidated Funds
InterestAndOtherIncomeOfConsolidatedFunds
121900000 usd
CY2024Q1 cg Realized Unrealized Gain Loss From Investments Of Consolidated Funds
RealizedUnrealizedGainLossFromInvestmentsOfConsolidatedFunds
82700000 usd
CY2023Q1 cg Realized Unrealized Gain Loss From Investments Of Consolidated Funds
RealizedUnrealizedGainLossFromInvestmentsOfConsolidatedFunds
145000000.0 usd
CY2024Q1 cg Realized Unrealized Gains Losses From Collateralized Loan Obligations Of Consolidated Funds
RealizedUnrealizedGainsLossesFromCollateralizedLoanObligationsOfConsolidatedFunds
-89700000 usd
CY2023Q1 cg Realized Unrealized Gains Losses From Collateralized Loan Obligations Of Consolidated Funds
RealizedUnrealizedGainsLossesFromCollateralizedLoanObligationsOfConsolidatedFunds
-141400000 usd
CY2024Q1 cg Net Investment Gains Losses Of Consolidated Funds
NetInvestmentGainsLossesOfConsolidatedFunds
-7000000.0 usd
CY2023Q1 cg Net Investment Gains Losses Of Consolidated Funds
NetInvestmentGainsLossesOfConsolidatedFunds
3600000 usd
CY2024Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-21200000 usd
CY2023Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-17400000 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
103900000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
162400000 usd
CY2024Q1 cg Realized Unrealized Gains Losses From Investments Of Consolidated Funds
RealizedUnrealizedGainsLossesFromInvestmentsOfConsolidatedFunds
82700000 usd
CY2023Q1 cg Realized Unrealized Gains Losses From Investments Of Consolidated Funds
RealizedUnrealizedGainsLossesFromInvestmentsOfConsolidatedFunds
145000000.0 usd
CY2024Q1 us-gaap Finite Lived Contractual Rights Gross
FiniteLivedContractualRightsGross
923300000 usd
CY2023Q4 us-gaap Finite Lived Contractual Rights Gross
FiniteLivedContractualRightsGross
924100000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
294400000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
262000000.0 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
628900000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
662100000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
103900000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
104000000.0 usd
CY2024Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
732800000 usd
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
766100000 usd
CY2024Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32600000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32800000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
98300000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
131000000.0 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
130900000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
120800000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
113700000 usd
CY2024Q1 cg Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
34200000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
628900000 usd
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2283100000 usd
CY2024Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
2259000000 usd
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2306700000 usd
CY2023Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
2281000000 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
17200000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
17200000 usd
CY2024Q1 cg Fair Value Of Collateralized Loan Obligation Assets
FairValueOfCollateralizedLoanObligationAssets
7100000000 usd
CY2023Q4 cg Fair Value Of Collateralized Loan Obligation Assets
FairValueOfCollateralizedLoanObligationAssets
6800000000 usd
CY2024Q1 cg Accrued Performance Fees Due To Employees And Advisors Included In Accrued Compensation
AccruedPerformanceFeesDueToEmployeesAndAdvisorsIncludedInAccruedCompensation
3939400000 usd
CY2023Q4 cg Accrued Performance Fees Due To Employees And Advisors Included In Accrued Compensation
AccruedPerformanceFeesDueToEmployeesAndAdvisorsIncludedInAccruedCompensation
4255800000 usd
CY2024Q1 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
110400000 usd
CY2023Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
498200000 usd
CY2024Q1 us-gaap Defined Benefit Pension Plan Liabilities Current
DefinedBenefitPensionPlanLiabilitiesCurrent
12400000 usd
CY2023Q4 us-gaap Defined Benefit Pension Plan Liabilities Current
DefinedBenefitPensionPlanLiabilitiesCurrent
13100000 usd
CY2024Q1 us-gaap Other Employee Related Liabilities Current And Noncurrent
OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent
111700000 usd
CY2023Q4 us-gaap Other Employee Related Liabilities Current And Noncurrent
OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent
155100000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
4173900000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
4922200000 usd
CY2024Q1 cg Accrued Performance Allocations And Incentive Fee Related Compensation Not Yet Paid
AccruedPerformanceAllocationsAndIncentiveFeeRelatedCompensationNotYetPaid
15100000 usd
CY2023Q4 cg Accrued Performance Allocations And Incentive Fee Related Compensation Not Yet Paid
AccruedPerformanceAllocationsAndIncentiveFeeRelatedCompensationNotYetPaid
44500000 usd
CY2024Q1 cg Performance Fee Expense Realized
PerformanceFeeExpenseRealized
266800000 usd
CY2023Q1 cg Performance Fee Expense Realized
PerformanceFeeExpenseRealized
103600000 usd
CY2024Q1 cg Unrealized Gain Loss On Performance Revenues And Fees Compensation Expense
UnrealizedGainLossOnPerformanceRevenuesAndFeesCompensationExpense
-339600000 usd
CY2023Q1 cg Unrealized Gain Loss On Performance Revenues And Fees Compensation Expense
UnrealizedGainLossOnPerformanceRevenuesAndFeesCompensationExpense
2100000 usd
CY2024Q1 cg Performance Allocations And Incentive Fee Expense
PerformanceAllocationsAndIncentiveFeeExpense
-72800000 usd
CY2023Q1 cg Performance Allocations And Incentive Fee Expense
PerformanceAllocationsAndIncentiveFeeExpense
105700000 usd
CY2024Q1 cg Unfunded Commitment
UnfundedCommitment
4200000000 usd
CY2024Q1 cg Unfunded Commitment To Be Paid By Senior Executives And Professionals
UnfundedCommitmentToBePaidBySeniorExecutivesAndProfessionals
3600000000 usd
CY2024Q1 cg Unfunded Commitments Origination And Syndication Of Loans
UnfundedCommitmentsOriginationAndSyndicationOfLoans
0 usd
CY2024Q1 cg Accrued Giveback Obligations
AccruedGivebackObligations
44000000 usd
CY2023Q4 cg Accrued Giveback Obligations
AccruedGivebackObligations
44000000 usd
CY2024Q1 cg Amount Of Giveback Obligation Of Current And Former Related Parties
AmountOfGivebackObligationOfCurrentAndFormerRelatedParties
20300000 usd
CY2024Q1 cg Amount Of Net Accrued Giveback Obligation Of Subsidiary
AmountOfNetAccruedGivebackObligationOfSubsidiary
23700000 usd
CY2024Q1 cg Number Of Employees Serving On Board Of Directors
NumberOfEmployeesServingOnBoardOfDirectors
2 employee
CY2024Q1 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
87500000 usd
CY2024Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
45000000 usd
CY2024Q1 us-gaap Receivable With Imputed Interest Effective Yield Interest Rate
ReceivableWithImputedInterestEffectiveYieldInterestRate
0.0702
CY2020Q1 cg Termination Of Tax Receivable Agreement Cost Per Partnership Unit Exchanged
TerminationOfTaxReceivableAgreementCostPerPartnershipUnitExchanged
1.50
CY2020Q1 cg Termination Of Tax Receivable Agreement Annual Installment Cost Per Partnership Unit Exchanged
TerminationOfTaxReceivableAgreementAnnualInstallmentCostPerPartnershipUnitExchanged
0.30
CY2020Q1 cg Termination Of Tax Receivable Agreement Obligation Discount
TerminationOfTaxReceivableAgreementObligationDiscount
11300000 usd
CY2024Q1 cg Percentage Of Estimated Realizable Tax Benefit To Be Paid By Corporate Taxpayers On Exchange Transactions
PercentageOfEstimatedRealizableTaxBenefitToBePaidByCorporateTaxpayersOnExchangeTransactions
0.85
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21900000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34300000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.18
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21
CY2024Q1 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
101400000 usd
CY2023Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
46900000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
669300000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
593100000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
33200000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
24600000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
65600000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
65600000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
360908247 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
369343601 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
100700000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
100700000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
362944260 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
365357833 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
360908247 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
369343601 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
362944260 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
365357833 shares
CY2023Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000 usd
CY2024Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1400000000 usd
CY2023Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000 usd
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
1256900000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
2853602 shares
CY2024Q1 cg Stock Repurchased During Period Value Excluding Excise Taxes
StockRepurchasedDuringPeriodValueExcludingExciseTaxes
130600000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
2998813 shares
CY2023Q1 cg Stock Repurchased During Period Value Excluding Excise Taxes
StockRepurchasedDuringPeriodValueExcludingExciseTaxes
100300000 usd
CY2024Q1 cg Stock Retired During Period Shares
StockRetiredDuringPeriodShares
481261 shares
CY2024Q1 cg Stock Retired During Period Value
StockRetiredDuringPeriodValue
19400000 usd
CY2023Q1 cg Stock Retired During Period Shares
StockRetiredDuringPeriodShares
0 shares
CY2023Q1 cg Stock Retired During Period Value
StockRetiredDuringPeriodValue
0 usd
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
3334863 shares
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
150000000.0 usd
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
2998813 shares
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
100300000 usd
CY2024Q1 us-gaap Excise Taxes Collected
ExciseTaxesCollected
600000 usd
CY2023Q1 us-gaap Excise Taxes Collected
ExciseTaxesCollected
0 usd
CY2023Q2 us-gaap Distribution Made To Limited Partner Distributions Paid Per Unit
DistributionMadeToLimitedPartnerDistributionsPaidPerUnit
0.35
CY2023Q2 us-gaap Distribution Made To Limited Partner Cash Distributions Paid
DistributionMadeToLimitedPartnerCashDistributionsPaid
126700000 usd
CY2023Q3 us-gaap Distribution Made To Limited Partner Distributions Paid Per Unit
DistributionMadeToLimitedPartnerDistributionsPaidPerUnit
0.35
CY2023Q3 us-gaap Distribution Made To Limited Partner Cash Distributions Paid
DistributionMadeToLimitedPartnerCashDistributionsPaid
126300000 usd
CY2023Q4 us-gaap Distribution Made To Limited Partner Distributions Paid Per Unit
DistributionMadeToLimitedPartnerDistributionsPaidPerUnit
0.35
CY2023Q4 us-gaap Distribution Made To Limited Partner Cash Distributions Paid
DistributionMadeToLimitedPartnerCashDistributionsPaid
126300000 usd
CY2024Q1 us-gaap Distribution Made To Limited Partner Distributions Paid Per Unit
DistributionMadeToLimitedPartnerDistributionsPaidPerUnit
0.35
CY2024Q1 us-gaap Distribution Made To Limited Partner Cash Distributions Paid
DistributionMadeToLimitedPartnerCashDistributionsPaid
126700000 usd
us-gaap Distribution Made To Limited Partner Distributions Paid Per Unit
DistributionMadeToLimitedPartnerDistributionsPaidPerUnit
1.40
us-gaap Distribution Made To Limited Partner Cash Distributions Paid
DistributionMadeToLimitedPartnerCashDistributionsPaid
506000000.0 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
39800000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
10176358 shares
CY2024Q1 cg Stock Retired During Period Shares
StockRetiredDuringPeriodShares
481261 shares
CY2024Q1 cg Stock Retired During Period Value
StockRetiredDuringPeriodValue
19400000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q1 us-gaap Revenues
Revenues
688400000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
560700000 usd
CY2024Q1 cg Net Investment Gains Losses Of Consolidated Funds
NetInvestmentGainsLossesOfConsolidatedFunds
-7000000.0 usd
CY2024Q1 cg Distributable Earnings
DistributableEarnings
120700000 usd
CY2024Q1 us-gaap Assets
Assets
20849500000 usd
CY2023Q1 us-gaap Revenues
Revenues
859000000.0 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
703000000.0 usd
CY2023Q1 cg Net Investment Gains Losses Of Consolidated Funds
NetInvestmentGainsLossesOfConsolidatedFunds
3600000 usd
CY2023Q1 cg Distributable Earnings
DistributableEarnings
159600000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
120700000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
159600000 usd
CY2024Q1 cg Performance Allocations And Incentive Fee Expense
PerformanceAllocationsAndIncentiveFeeExpense
-72800000 usd
CY2024Q1 cg Net Performance Fees
NetPerformanceFees
-84200000 usd
CY2023Q1 cg Performance Allocations And Incentive Fee Expense
PerformanceAllocationsAndIncentiveFeeExpense
105700000 usd
CY2023Q1 cg Net Performance Fees
NetPerformanceFees
55100000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1276500000 usd
CY2024Q1 cg Cash And Cash Equivalents At Carrying Value Held At Consolidated Funds
CashAndCashEquivalentsAtCarryingValueHeldAtConsolidatedFunds
426000000.0 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
1400000 usd
CY2024Q1 cg Accrued Performance Based Capital Allocation
AccruedPerformanceBasedCapitalAllocation
5567600000 usd
CY2024Q1 us-gaap Investments
Investments
9473200000 usd
CY2024Q1 cg Investments Of Consolidated Funds
InvestmentsOfConsolidatedFunds
7458600000 usd
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
624100000 usd
CY2024Q1 cg Other Receivables Net Current Consolidated Funds
OtherReceivablesNetCurrentConsolidatedFunds
204100000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
162800000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
349300000 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
88500000 usd
CY2024Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
732800000 usd
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
52200000 usd
CY2024Q1 us-gaap Assets
Assets
20849500000 usd
CY2024Q1 us-gaap Loans Payable
LoansPayable
2259000000 usd
CY2024Q1 cg Loan Payable To Affiliate Of Consolidated Funds
LoanPayableToAffiliateOfConsolidatedFunds
6535100000 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
375200000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
4173900000 usd
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
203600000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
391100000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
26200000 usd
CY2024Q1 cg Other Liabilities Of Consolidated Funds
OtherLiabilitiesOfConsolidatedFunds
598500000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
502900000 usd
CY2024Q1 cg Accrued Giveback Obligations
AccruedGivebackObligations
44000000.0 usd
CY2024Q1 us-gaap Liabilities
Liabilities
15109500000 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
3600000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3513900000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1868200000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-315000000.0 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
669300000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5740000000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20849500000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1440300000 usd
CY2023Q4 cg Cash And Cash Equivalents At Carrying Value Held At Consolidated Funds
CashAndCashEquivalentsAtCarryingValueHeldAtConsolidatedFunds
346000000.0 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
1800000 usd
CY2023Q4 cg Accrued Performance Based Capital Allocation
AccruedPerformanceBasedCapitalAllocation
6169900000 usd
CY2023Q4 us-gaap Investments
Investments
9955300000 usd
CY2023Q4 cg Investments Of Consolidated Funds
InvestmentsOfConsolidatedFunds
7253100000 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
691600000 usd
CY2023Q4 cg Other Receivables Net Current Consolidated Funds
OtherReceivablesNetCurrentConsolidatedFunds
141000000.0 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
161500000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
332200000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
70600000 usd
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
766100000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
16500000 usd
CY2023Q4 us-gaap Assets
Assets
21176000000 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
2281000000 usd
CY2023Q4 cg Loan Payable To Affiliate Of Consolidated Funds
LoanPayableToAffiliateOfConsolidatedFunds
6486500000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
333800000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
4922200000 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
275900000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
140300000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
45300000 usd
CY2023Q4 cg Other Liabilities Of Consolidated Funds
OtherLiabilitiesOfConsolidatedFunds
374400000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
488100000 usd
CY2023Q4 cg Accrued Giveback Obligations
AccruedGivebackObligations
44000000.0 usd
CY2023Q4 us-gaap Liabilities
Liabilities
15391500000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3600000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3403000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2082100000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-297300000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
593100000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5784500000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21176000000 usd
CY2024Q1 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
-83900000 usd
CY2024Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
57600000 usd
CY2024Q1 cg Interest And Other Income Of Consolidated Funds
InterestAndOtherIncomeOfConsolidatedFunds
164900000 usd
CY2024Q1 us-gaap Revenues
Revenues
688400000 usd
CY2024Q1 us-gaap Salaries And Wages
SalariesAndWages
221900000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
108300000 usd
CY2024Q1 cg Performance Allocations And Incentive Fee Expense
PerformanceAllocationsAndIncentiveFeeExpense
-72800000 usd
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
257400000 usd
CY2024Q1 cg General Administrative And Other Expense
GeneralAdministrativeAndOtherExpense
147700000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
30800000 usd
CY2024Q1 cg Interest And Other Expenses Of Consolidated Funds
InterestAndOtherExpensesOfConsolidatedFunds
124600000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-200000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
560700000 usd
CY2024Q1 cg Net Investment Gains Losses Of Consolidated Funds
NetInvestmentGainsLossesOfConsolidatedFunds
-7000000.0 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
120700000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21900000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
98800000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
33200000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
65600000 usd
CY2023Q1 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
172500000 usd
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
44000000.0 usd
CY2023Q1 cg Interest And Other Income Of Consolidated Funds
InterestAndOtherIncomeOfConsolidatedFunds
121900000 usd
CY2023Q1 us-gaap Revenues
Revenues
859000000.0 usd
CY2023Q1 us-gaap Salaries And Wages
SalariesAndWages
260200000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
54400000 usd
CY2023Q1 cg Performance Allocations And Incentive Fee Expense
PerformanceAllocationsAndIncentiveFeeExpense
105700000 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
420300000 usd
CY2023Q1 cg General Administrative And Other Expense
GeneralAdministrativeAndOtherExpense
159200000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
29700000 usd
CY2023Q1 cg Interest And Other Expenses Of Consolidated Funds
InterestAndOtherExpensesOfConsolidatedFunds
93700000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-100000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
703000000.0 usd
CY2023Q1 cg Net Investment Gains Losses Of Consolidated Funds
NetInvestmentGainsLossesOfConsolidatedFunds
3600000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
159600000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34300000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
125300000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
24600000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
100700000 usd

Files In Submission

Name View Source Status
cg-20240331_pre.xml Edgar Link unprocessable
0001527166-24-000051-index-headers.html Edgar Link pending
0001527166-24-000051-index.html Edgar Link pending
0001527166-24-000051.txt Edgar Link pending
0001527166-24-000051-xbrl.zip Edgar Link pending
cg-20240331.htm Edgar Link pending
cg-20240331.xsd Edgar Link pending
cg-20240331_g1.jpg Edgar Link pending
cg-20240331_g2.gif Edgar Link pending
cg-20240331_g3.gif Edgar Link pending
cg2024033110-q_exx22.htm Edgar Link pending
cg20240331exhibit101.htm Edgar Link pending
cg20240331exhibit102.htm Edgar Link pending
cg20240331exhibit103.htm Edgar Link pending
cg20240331exhibit311.htm Edgar Link pending
cg20240331exhibit312.htm Edgar Link pending
cg20240331exhibit321.htm Edgar Link pending
cg20240331exhibit322.htm Edgar Link pending
cg202433110-q.pdf Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
cg-20240331_cal.xml Edgar Link unprocessable
cg-20240331_def.xml Edgar Link unprocessable
cg-20240331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cg-20240331_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending